Anemia Features
Renal Stenting and the CORAL Study: Interview with Lance Dworkin, MD
CORAL study chair Lance Dworkin, MD, discusses the controversial finding with Renal & Urology News.
Latest Anemia News
Low Hemoglobin in CKD Patients Predicts Worse Outcomes
Levels below 10 g/dL found to increase risk of a composite endpoint of all-cause mortality, cerebrovascular events, and myocardial infarction.
Ferric Citrate Controls Phosphorus, Cuts ESA Use
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
ESA Use May Lower Risk of Transfusion
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Earlier Use of ESAs Benefits Non-Dialysis Kidney Disease (CKD) Patients
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.
Giving Vitamin B6 Ups Resistance to ESAs
New finding on vitamin B6 is the opposite of what investigators hypothesized on patients with anemia.
Data Challenge IV Iron Withholding Guideline
IV iron in anemia hemodialysis patients hospitalized for bacterial infections found not to worsen outcomes.
Anemia Management Practices Shift, Study Finds
Use of erythropoiesis-stimulating agents in anemia patients decreased, while use of iron increased.
Prolonged Bleeding Times Linked to Severe Anemia in Chronic Kidney Disease (CKD)
Hemoglobin level below 8 mg/dL associated with 82% increased odds of prolonged bleeding time with anemia.
Anemia Found to Affect Renal Recovery from Acute Kidney Injury (AKI)
Highest quintile of hemoglobin associated with 6-fold increased odds of complete or partial recovery of anemia in acute kidney injury (AKI).
Alternate Night Home Hemodialysis Improves Anemia
Researchers believe nocturnal home hemodialysis (NHHD) performed every other night may be superior to NHHD performed 6 or 7 times a week.
Body Fat May Improve Anemia Drug Response
Hemodialysis patients with a higher percentage of fat tissue respond better to erythropoiesis-stimulating agents.
Pre-Surgery Anemia Ups CKD Patients' Risks
Low hemoglobin levels increase the risk of death, sepsis, and cerebrovascular accidents following cardiac surgery.
ESA Use in Dialysis Patients May Increase Their Cancer Risk
Doses higher than 70 μg per week were associated with a 77% greater risk of cancer compared with non-use of the agents.
Ascorbic Acid Found to Reduce Darbepoetin Requirement
It also was associated with high hemoglobin levels and reduced levels of C-reactive protein.
Value of ESAs in Avoiding Transfusion Questionable
In 3 trials, the annual cost for preventing 1 patient from being transfused varied from $61,188 to $317,988.